Ethylene chlorohydrin
|
CAS
107-07-3
|
CH2ClCH2OH
|
RTECS
KK0875000
|
Synonyms & Trade Names
2-Chloroethanol, 2-Chloroethyl alcohol, Ethylene chlorhydrin
|
DOT ID & Guide
1135 / 131
|
Exposure Limits
|
NIOSH REL: C 1 ppm (3 mg/m3) [skin]
|
OSHA PEL†: TWA 5 ppm (16 mg/m3) [skin]
|
IDLH
7 ppm
See: 107073
|
Conversion
1 ppm = 3.29 mg/m3
|
Physical Description
Colorless liquid with a faint, ether-like odor.
|
MW: 80.5
|
BP: 262°F
|
FRZ: -90°F
|
Sol: Miscible
|
VP: 5 mmHg
|
IP: 10.90 eV
|
|
Sp.Gr: 1.20
|
Fl.P: 140°F
|
UEL: 15.9%
|
LEL: 4.9%
|
|
Class IIIA Combustible Liquid: Fl.P. at or above 140°F and below 200°F.
|
Incompatibilities & Reactivities
Strong oxidizers, strong caustics, water or steam
|
Measurement Methods
NIOSH 2513; OSHA 7
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet or contaminated
Change: No recommendation
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Water flush immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
NIOSH
Up to 7 ppm: (APF = 10) Any supplied-air respirator* (APF = 50) Any self-contained breathing apparatus with a full facepiece
Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Irritation mucous membrane; nausea, vomiting; dizziness, incoordination; numbness; visual disturbance; headache; thirst; delirium; low blood pressure; collapse, shock, coma; liver, kidney damage
|
Target Organs
respiratory system, liver, kidneys, central nervous system, cardiovascular system, eyes
|
See also: INTRODUCTION
See ICSC CARD: 0236 See MEDICAL TESTS: 0101
|